Charitable investments
GSK IMPACT Awards
The 2024 GSK IMPACT Award winners are transforming lives through innovative programs that address hunger, mentorship, homelessness, and education, making communities healthier and stronger. Tune in to the virtual ceremony on Thursday, November 21, from 12:00 pm to 1:00 pm ET to celebrate their work.
Investors
We announced our quarter 1 2024 results on Wednesday, May 1st.
Press releases
- Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
- US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD
- Belantamab mafodotin combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
GSK Global links
Visit our Global site for additional features